Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future Growth
-- Key additions deepen drug development expertise and position the Company to advance pipeline --VANCOUVER, British Columbia, Feb. 10, 2021...
News
ORYZON to Present New Clinical Data and Corporate Updates at Conferences in February and March
2021 BIO CEO & Investor Digital Conference15th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD 2021 H.C. Wainwright Global Life...
Protech Home Medical to Present at The MicroCap Rodeo Winter Wonderland Conference
Webcasted Presentation to Be Held Tuesday, February 16, 2021 at 3:30PM (EST)CINCINNATI, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Protech Home...
Cognition Therapeutics Publishes Biomarker Findings from Clinical Study of CT1812 Supporting Positive Impact on Synapse Biology
Pittsburgh, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative...
Vericel to Report Fourth-Quarter 2020 Financial Results on February 24, 2021
CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Panbela Provides Update on Current Clinical Trial: Decision to Hold Administration of SBP-101
Panbela is studying patients with pancreatic cancer testing investigative agent SBP-101 when used in combination with standard of care agents...
CymaBay Therapeutics to Present at the SVB Leerink 10th Annual Global Healthcare Conference
NEWARK, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing...
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
MENLO PARK, Calif. and BOSTON, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company...
Evaxion Biotech Closes its U.S. Initial Public Offering of American Depositary Shares
COPENHAGEN, Denmark, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech, a clinical-stage biotechnology company specializing in the development of AI-driven...
Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market
Vancouver, Canada, Feb. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN)...
Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider to Conduct Observational Study
TORONTO and KINGSTON, Jamaica, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc., through its wholly-owned subsidiary Psyence Therapeutics Corp....
Progenity to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record...
Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China
Agreement will expand clinical development for a potent and selective small molecule targeting TBL1, a downstream target in the Wnt/β-catenin...
Terns Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
FOSTER CITY, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Maravai LifeSciences Expands Its Intellectual Property Portfolio
Advancement Expected to Further Accelerate Development of mRNA Vaccines and TherapeuticsSAN DIEGO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences,...
Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology
Provides Expanded Protection to Seminal Patents Related to DNAbilizeHOUSTON, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a...
Tonix Pharmaceuticals to Participate in BIO CEO & Investor Digital Conference
CHATHAM, N.J., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage...
Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors
NEW YORK & SAN DIEGO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...
Kamada Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development Activities
Full-Year 2020 Revenues were $133.2 Million, In-Line with the Company’s Guidance; Adjusted EBITDA for 2020 was $25.1 MillionKamada Enters U.S....
CareDx to to Participate in Upcoming BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused...